Rapamycin (Tablets)

DRUG2 trials

Sponsors

University of Chicago, The Christ Hospital

Conditions

Advanced CancerAgingMetastatic Cancer

Early Phase 1

A Pilot Study on Reverse Aging (The REVERSE Study)

Active, not recruitingNCT07354620

The Christ HospitalAging

Start: 2025-02-15End: 2026-05-01Updated: 2026-01-21

Phase 1

Rapamycin Plus Bevacizumab in Advanced Cancers

CompletedNCT00667485

University of ChicagoAdvanced Cancer, Metastatic Cancer

Start: 2008-04-30End: 2012-05-31Updated: 2014-01-17